EXENATIDE , VERAPAMIL clinical trials

A GLP-1 receptor PET imaging add-on study within the VERA-T1D trial investigating the effects on beta cell mass (Image-VER-A-T1D)

This study is looking at how two treatments, exenatide and verapamil, might affect the cells in the pancreas that make insulin in people with type 1 diabetes. We're using a special scan to see if these cells change over 12 months.